A recent article in Engineering describes the development of a protein-based nanocomposite hydrogel designed to deliver two therapeutic agents—dexamethasone (Dex) and kartogenin (KGN)—to support cartilage repair. The hydrogel is engineered to modulate immune responses and promote the formation of cartilage tissue through controlled drug release.
Background
Cartilage has a limited ability to repair itself due to its avascular nature, which restricts nutrient flow and cell migration. Various scaffold materials, including natural polymers and composites, have been tested for cartilage repair. However, many of these face limitations such as poor mechanical strength, weak cell signaling, and inconsistent drug delivery.
Hydrogels are promising in this context because they are hydrophilic, biodegradable, and can mimic the properties of natural tissue. Designing hydrogels that coordinate immune regulation and tissue regeneration, however, remains a complex challenge.
Dexamethasone is a corticosteroid with strong anti-inflammatory effects. It can shift macrophages toward an M2 phenotype, which supports tissue repair. Kartogenin is a small molecule known to stimulate mesenchymal stem cells (MSCs) to differentiate into chondrocytes, enhancing cartilage formation. Combining both agents in a single hydrogel aims to first reduce inflammation and then encourage cartilage regeneration.
The Current Study
Researchers created a silk fibroin-based nanocomposite hydrogel loaded with Dex and KGN. KGN was covalently linked to silk proteins to form nanospheres (SPNs) that release the drug over time. Dex was incorporated non-covalently via hydrogen bonding with the silk matrix, forming a Dex-HLC complex intended for rapid release.
The hydrogel network was stabilized using enzymatic crosslinking with transglutaminase, which promoted covalent bonding between amino acid residues in the silk fibroin. This structure allowed for staged drug release: Dex would be released early to manage inflammation, and KGN would be released gradually during the tissue regeneration phase.
The hydrogel’s physical and chemical properties—such as strength, degradation rate, and drug release behavior—were assessed through spectroscopy, degradation studies, and release tests. Cytocompatibility was evaluated using cultures of MSCs and macrophages to monitor adhesion, growth, and differentiation.
An in vivo rabbit model of cartilage defect was used to test the hydrogel’s repair performance. After implantation, tissue samples were evaluated through histological staining (H&E, Safranin O), immunohistochemistry for inflammation and cartilage markers, and micro-CT imaging to assess cartilage and bone formation.
Results and Discussion
The hydrogel formed a stable and elastic structure with mechanical properties similar to native cartilage. It degraded at a rate aligned with typical cartilage healing timelines. In early-stage testing, Dex was released quickly and reduced inflammation, as shown by lower levels of cytokines such as TNF-α and IL-6. Macrophage analysis showed a shift from the M1 (inflammatory) to M2 (anti-inflammatory) phenotype after Dex exposure.
KGN was released over a longer period, supporting the differentiation of MSCs into chondrocytes. This was confirmed by increased expression of markers like type II collagen, SOX-9, and aggrecan. At the same time, expression of hypertrophy-associated markers like RUNX2 decreased, while RUNX1 expression increased, indicating stable chondrogenic differentiation and reduced risk of cartilage overgrowth.
In the rabbit model, defects treated with the hydrogel showed significant formation of hyaline-like cartilage, with organized extracellular matrix and tissue structures resembling native cartilage. These regions showed higher levels of cartilage matrix components and new bone formation compared to control groups. Immunohistochemical staining revealed reduced inflammatory signaling and increased collagen type II levels, confirming tissue regeneration with limited inflammation and hypertrophy.
Conclusion
This study describes a dual-drug nanocomposite hydrogel for cartilage repair that delivers Dex for early inflammation control and KGN for long-term cartilage regeneration. The material showed favorable mechanical performance, cell compatibility, and regenerative effects in a rabbit cartilage defect model. The combination of immune modulation and support for chondrogenesis represents a comprehensive strategy for tissue engineering.
While initial results are encouraging, further research is needed to refine drug delivery profiles, evaluate long-term outcomes, and confirm safety in larger animal models. This approach highlights the potential of responsive hydrogel systems in addressing challenges in cartilage repair and osteoarthritis treatment.
Journal Reference
Lei, H., Fan, D. (2025). Dual drug delivery nanocomposite hydrogel for cartilage repair: immunomodulation and chondrogenesis. Engineering. DOI: 10.1016/j.eng.2025.05.010, https://www.sciencedirect.com/science/article/pii/S2095809925002875?via%3Dihub
News
Researchers Discover a Hidden Vitamin D Problem That Persists Year-Round
A new study suggests that some groups may not experience the expected seasonal boost in vitamin D levels, even during the sunniest months of the year. Many people assume that spending more time outdoors [...]
Researchers Solve the Mystery Behind a Billion-Dollar Dental Implant Disease
Researchers have uncovered why a common and costly dental implant infection often resists antibiotics. Dental implants have helped tens of millions of people regain a full set of stable, functional teeth, something traditional dentures [...]
Nanoparticles inspired by lung fluid improve therapies targeting respiratory system
The CIC biomaGUNE Center for Cooperative Research in Biomaterials has developed pulmonary surfactant nanoparticles (the blend of lipids and proteins that line the alveoli and enables breathing), which are encapsulated [...]
Scientists Finally Uncover How a “Forever Chemical” Causes Birth Defects
PFDA, a PFAS “forever chemical,” can cause craniofacial birth defects by disrupting retinoic acid regulation during fetal development, revealing the first clear molecular mechanism behind the link. Researchers have long linked perfluoroalkyl and polyfluoroalkyl substances (PFAS), [...]
Scientists Have Discovered These Deadly Parasites Are Secretly Swapping DNA
Leishmania parasites appear to evolve through widespread genetic exchange, reshaping assumptions about how they adapt and spread. A parasite long thought to spread mostly by cloning itself may be far more genetically dynamic than [...]
Stanford’s Revolutionary New Microscope Reveals Living Cells in Stunning Detail
Stanford researchers have developed a microscope that can show how nanostructures interact inside living cells at the highest resolution achieved so far. The view into living cells just got better. Stanford researchers have merged [...]
What Bundibugyo Ebola vaccines and treatments are under development
By Mariam Sunny and Jennifer Rigby May 29 (Reuters) – Global health authorities are racing to identify medical options to help contain an Ebola outbreak in eastern Democratic Republic of Congo, linked to the [...]
Why More People in Their 30s Are Suddenly Getting Colon Cancer
A major Swiss study found that colorectal cancer is becoming increasingly common in adults under 50, even as rates decline in older age groups. Researchers in Switzerland have identified a concerning trend: while colorectal [...]
Researchers Compare MS Models to Human Tissue in Search for Better Therapies
Researchers identified key differences between two widely used multiple sclerosis models, showing how each can better study myelin damage, immune responses, and repair. The findings may improve efforts to develop treatments that restore lost [...]
Scientists Discover Genetic “Off Switch” That Supercharges CAR T Cells Against Cancer
A new study reveals a possible way to make CAR T-cell therapy more durable and effective by targeting a single gene-regulating protein. CAR T-cell therapy is widely seen as a breakthrough in personalized cancer [...]
New Vitamin B12-Based Therapy Could Change How Brain Cancer Is Treated
Researchers have identified a vitamin B12–based compound that appears capable of crossing the blood–brain barrier and selectively accumulating in glioblastoma tissue. For decades, one of the biggest problems in brain cancer treatment has had [...]
Simple Fiber Supplement Cuts Knee Arthritis Pain in Just 6 Weeks, Study Finds
A daily inulin supplement may help reduce knee osteoarthritis pain while revealing a possible link between gut health, muscle function, and pain sensitivity. For millions of people living with knee osteoarthritis, managing chronic pain [...]
This Common Vitamin May Help Stop Prediabetes From Turning Into Diabetes
Vitamin D may help prevent type 2 diabetes in people with specific genetic variations, offering a possible path toward personalized diabetes prevention. More than 40% of U.S. adults have prediabetes, a condition in which [...]
Ebola, hantavirus: Is the world prepared for the next pandemic?
Funding cuts to health research and a growing antivaccine movement are making it harder than ever to respond to viruses. The World Health Organization (WHO) has declared that an Ebola outbreak in Uganda and [...]
May 2026 Healthcare News and Trends: Market Signals That Matter
Artificial intelligence is dominating headlines, telehealth has settled into a new normal, and digital health continues to promise transformation. However, much of what is being discussed in healthcare today reflects potential rather than reality. [...]
Scientists Rewire Donor Stem Cells To Outsmart Aggressive Blood Cancers
Researchers have tested a gene-edited stem cell transplant designed to shield healthy blood-forming cells from powerful cancer-targeting immunotherapies. For patients with highly aggressive blood cancers, stem cell transplantation can offer a rare chance at [...]
